New trial aims to stop stroke damage before it worsens
NCT ID NCT07365150
Summary
This study is testing if a drug called tranexamic acid (TXA) can help control brain damage after a specific type of stroke called an intracerebral hemorrhage (brain bleed). Researchers are trying a new, more precise method to select which patients might benefit most, based on where and how large the bleed is. The goal is to see if this targeted approach can prevent the bleed from getting worse and improve patients' recovery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTRACEREBRAL HEMORRHAGE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Pamela Youde Nethersole Eastern Hospital
NOT_YET_RECRUITINGHong Kong, Hong Kong
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Prince of Wales Hospital
RECRUITINGHong Kong, Hong Kong
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The University of Hong Kong
RECRUITINGHong Kong, Hong Kong
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.